收藏切换
Novel strategy in Dengzhan Shengmai capsule metabolites analysis based on the prediction database
收藏切换
PDF
Yuan-yuan LI, Bo-wen ZHENG, Cong-yu MA, Ning SHENG*, Jin-lan ZHANG*
Acta Pharmaceutica Sinica | 2023, 58(8) : 2468 - 2475
Less
收藏切换
Acta Pharmaceutica Sinica | 2023, 58(8): 2468-2475
Novel strategy in Dengzhan Shengmai capsule metabolites analysis based on the prediction database
Full
Yuan-yuan LI, Bo-wen ZHENG, Cong-yu MA, Ning SHENG*, Jin-lan ZHANG*
Affiliations
  • State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China
Published: 2023-08-12 doi: 10.16438/j.0513-4870.2023-0528
Outline
收藏切换

Dengzhan Shengmai capsule, as a compound Chinese patent medicine, consists of four herbs: Herba Erigerontis, Ginseng, Ophiopogon, and Schisandrae Chinensis Fructus, and contains significant components of flavonoids, lignans, saponins, and organic acids. It is widely used clinically to treat cerebrovascular diseases such as chronic cerebral hypoperfusion and dementia with remarkable efficacy. This study proposes a research strategy for multi-component traditional Chinese medicine metabolites based on prediction databases and unfolds the analysis using Dengzhan Shengmai capsule as an example. Using the UPLC-Q-TOF/MS method, the analytical method was established and detected biological samples such as urine, feces, and bile of rats before and after administration based on the prediction of theoretical metabolites of Dengzhan Shengmai capsule. The possible secondary fragment ion information of metabolites was identified by comparing the detected results with prediction databases. The metabolites were identified based on the archetypal component mass spectrometric cleavage law and multistage mass spectrometric data. 51 metabolites, mainly flavonoid, organic acid, and lignan constituents, were finally identified from rat biosamples based on 306 theoretical metabolites of Dengzhan Shengmai capsule. This study provides a new strategy for the identification of metabolites in vivo and the analysis of metabolic pathways of TCM. The study complied with the procedures established by the Animal Experiment Ethics Committee of the Institute of Materia Medica, Chinese Academy of Medical Sciences and passed the animal experiment ethics examine (No. 00003645).

Dengzhan Shengmai  /  UPLC-Q-TOF-MS  /  identification of metabolites  /  metabolism of TCM
Yuan-yuan LI, Bo-wen ZHENG, Cong-yu MA, Ning SHENG, Jin-lan ZHANG. Novel strategy in Dengzhan Shengmai capsule metabolites analysis based on the prediction database[J]. Acta Pharmaceutica Sinica, 2023 , 58 (8) : 2468 -2475 . DOI: 10.16438/j.0513-4870.2023-0528
Year 2023 volume 58 Issue 8
PDF
265
115
Cite this Article
BibTeX
Article Info
doi: 10.16438/j.0513-4870.2023-0528
  • Receive Date:2023-04-29
  • Online Date:2025-11-21
  • Published:2023-08-12
Article Data
Affiliations
History
  • Received:2023-04-29
  • Revised:2023-07-13
Funding
Affiliations
    State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China
References
Share
https://castjournals.cast.org.cn/joweb/yxxb/EN/10.16438/j.0513-4870.2023-0528
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数

Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)

Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT